{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/65bafbfaf834400016f74e65?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Thursday, February 1, 2024","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/1706752986623-e77bd2e3df2e8018794ad27e84547785.jpeg?height=200","description":"<p>Cigna officially offloads its Medicare Advantage business to Health Care Service Corporation.&nbsp;The Biden Administration will negotiate on behalf of states to provide a groundbreaking gene therapy for Medicaid beneficiaries with sickle cell disease.&nbsp;And, the Dana Farber Cancer Institute is issuing corrections and retracting some research papers amid falsification allegations.&nbsp;That’s coming up on today’s episode of Gist Healthcare Daily.</p><p><br></p>","author_name":"Gist Healthcare Daily"}